Furlani, Lara
 Distribuzione geografica
Continente #
NA - Nord America 137
EU - Europa 93
AS - Asia 59
OC - Oceania 2
SA - Sud America 1
Totale 292
Nazione #
US - Stati Uniti d'America 137
CN - Cina 41
GB - Regno Unito 30
IT - Italia 13
FR - Francia 12
SE - Svezia 12
FI - Finlandia 7
BE - Belgio 6
DE - Germania 6
VN - Vietnam 6
IN - India 5
IE - Irlanda 4
SG - Singapore 3
AU - Australia 2
ID - Indonesia 2
BY - Bielorussia 1
CL - Cile 1
EE - Estonia 1
HK - Hong Kong 1
IR - Iran 1
UA - Ucraina 1
Totale 292
Città #
Chandler 27
Southend 26
Woodbridge 20
Ann Arbor 16
Wilmington 11
Beijing 10
New York 9
Ashburn 8
Brussels 6
Falls Church 6
Hebei 5
Shenyang 5
Dublin 4
Lawrence 4
Princeton 4
Asiago 3
Helsinki 3
Hyderabad 3
Jinan 3
Nanjing 3
Verona 3
Zhengzhou 3
Boardman 2
Dong Ket 2
Jakarta 2
Redmond 2
Redwood City 2
Tianjin 2
Xi'an 2
Andover 1
Charlotte 1
Chions 1
Chiusa 1
Guangzhou 1
Jacksonville 1
Kochi 1
Los Angeles 1
Martignacco 1
Milan 1
Minsk 1
Mira 1
Norwalk 1
San Jose 1
Sindelfingen 1
Sydney 1
Taizhou 1
Tallinn 1
Wuhan 1
Totale 215
Nome #
slan+ monocytes and macrophages mediate CD20-dependent B cell lymphoma elimination via ADCC and ADCP 105
Short-term, intensive chemotherapy regimen is equally effective in Burkitt lymphoma (BL) and in the novel WHO 2008 entity “B-cell lymphoma intermediate between DLBCL and BL". 80
Modified HyperCVAD and rituximab for the treatment of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. 54
Psychological impact of Covid-19 pandemic on oncological patients: a survey in Northern Italy 53
A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements 7
Totale 299
Categoria #
all - tutte 961
article - articoli 550
book - libri 0
conference - conferenze 411
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.922


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 5 1 0 0 3 1 1 3 0 3 1 4
2020/202131 3 3 3 4 4 0 0 1 1 0 4 8
2021/202270 8 16 1 1 8 9 1 2 5 1 8 10
2022/202365 5 8 9 14 4 16 1 1 7 0 0 0
2023/202453 0 8 2 6 9 11 0 3 1 3 7 3
Totale 299